TransMedics Group, a medical device company that provides a system for donor organ transport, raised $91 million by offering 5.7 million shares at $16, the midpoint of the $15 to $17 range. The company had originally filed to offer 4.7 million shares at the same range of $15-$17.
TransMedics Group plans to list on the Nasdaq under the symbol TMDX. Morgan Stanley and J.P. Morgan acted as lead managers on the deal.
